🚀 VC round data is live in beta, check it out!
Animalcare Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Animalcare Group and similar public comparables like ProKidney, Foghorn Therapeutics, Artiva Biotherapeutics, Duopharma Biotech and more.
Animalcare Group Overview
About Animalcare Group
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of pharmaceutical products. The company has a presence in Belgium, The Netherlands, Germany, Italy, Portugal, the European Union - Other, Asia, Middle East Africa, Spain, the United Kingdom, and Other Countries of which Spain derives the majority of the revenue to the company.
Founded
1972
HQ
Employees
201
Website
Sectors
Financials (LTM)
EV
$326M
Animalcare Group Financials
Animalcare Group reported last 12-month revenue of $120M and EBITDA of $23M.
In the same LTM period, Animalcare Group generated $23M in EBITDA and $14M in net income.
Revenue (LTM)
Animalcare Group P&L
In the most recent fiscal year, Animalcare Group reported revenue of $100M and EBITDA of $18M.
Animalcare Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $120M | XXX | $100M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $56M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 56% | XXX | XXX | XXX |
| EBITDA | $23M | XXX | $18M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $14M | XXX | $25M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 25% | XXX | XXX | XXX |
| Net Debt | — | — | $12M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Animalcare Group Stock Performance
Animalcare Group has current market cap of $311M, and enterprise value of $326M.
Market Cap Evolution
Animalcare Group's stock price is $4.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $326M | $311M | 34.3% | XXX | XXX | XXX | $0.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAnimalcare Group Valuation Multiples
Animalcare Group trades at 2.7x EV/Revenue multiple, and 14.2x EV/EBITDA.
EV / Revenue (LTM)
Animalcare Group Financial Valuation Multiples
As of April 18, 2026, Animalcare Group has market cap of $311M and EV of $326M.
Equity research analysts estimate Animalcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Animalcare Group has a P/E ratio of 22.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $311M | XXX | $311M | XXX | XXX | XXX |
| EV (current) | $326M | XXX | $326M | XXX | XXX | XXX |
| EV/Revenue | 2.7x | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | 14.2x | XXX | 18.0x | XXX | XXX | XXX |
| EV/EBIT | 18.0x | XXX | 34.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.8x | XXX | XXX | XXX |
| P/E | 22.6x | XXX | 12.4x | XXX | XXX | XXX |
| EV/FCF | 41.3x | XXX | 28.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Animalcare Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Animalcare Group Margins & Growth Rates
Animalcare Group's revenue in the last 12 month grew by 7%.
Animalcare Group's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Animalcare Group's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Animalcare Group's rule of X is 39% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Animalcare Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | 27% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 46% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Animalcare Group Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Animalcare Group | XXX | XXX | XXX | XXX | XXX | XXX |
| ProKidney | XXX | XXX | XXX | XXX | XXX | XXX |
| Foghorn Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Artiva Biotherapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Duopharma Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Amarin Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Animalcare Group M&A Activity
Animalcare Group acquired XXX companies to date.
Last acquisition by Animalcare Group was on XXXXXXXX, XXXXX. Animalcare Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Animalcare Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAnimalcare Group Investment Activity
Animalcare Group invested in XXX companies to date.
Animalcare Group made its latest investment on XXXXXXXX, XXXXX. Animalcare Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Animalcare Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Animalcare Group
| When was Animalcare Group founded? | Animalcare Group was founded in 1972. |
| Where is Animalcare Group headquartered? | Animalcare Group is headquartered in United Kingdom. |
| How many employees does Animalcare Group have? | As of today, Animalcare Group has over 201 employees. |
| Who is the CEO of Animalcare Group? | Animalcare Group's CEO is Jennifer Ann Julia Winter. |
| Is Animalcare Group publicly listed? | Yes, Animalcare Group is a public company listed on London Stock Exchange. |
| What is the stock symbol of Animalcare Group? | Animalcare Group trades under ANCR ticker. |
| When did Animalcare Group go public? | Animalcare Group went public in 2008. |
| Who are competitors of Animalcare Group? | Animalcare Group main competitors are ProKidney, Foghorn Therapeutics, Artiva Biotherapeutics, Duopharma Biotech. |
| What is the current market cap of Animalcare Group? | Animalcare Group's current market cap is $311M. |
| What is the current revenue of Animalcare Group? | Animalcare Group's last 12 months revenue is $120M. |
| What is the current revenue growth of Animalcare Group? | Animalcare Group revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Animalcare Group? | Current revenue multiple of Animalcare Group is 2.7x. |
| Is Animalcare Group profitable? | Yes, Animalcare Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Animalcare Group? | Animalcare Group's last 12 months EBITDA is $23M. |
| What is Animalcare Group's EBITDA margin? | Animalcare Group's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Animalcare Group? | Current EBITDA multiple of Animalcare Group is 14.2x. |
| What is the current FCF of Animalcare Group? | Animalcare Group's last 12 months FCF is $8M. |
| What is Animalcare Group's FCF margin? | Animalcare Group's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Animalcare Group? | Current FCF multiple of Animalcare Group is 41.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.